Bacterial proteomics and its role in antibacterial drug discovery

Mass Spectrometry Reviews

Volumn 24, Issue 4, 2005, Pages 549-565

  Brötz Oesterhelt, Heike ^a   Bandow, Julia Ellsabeth ^b   Labischinski, Harald ^a  

^a BAYER PHARMA AG   (Germany)

^b PFIZER INC   (United States)

Author keywords

2D gel electrophoresis; Antibiotics; Bacteria; Drug discovery; Proteomics

Indexed keywords

2D GEL ELECTROPHORESIS; BACTERIAL PROTEOMES; DRUG DISCOVERY; PROTEOMICS;

ANTIBIOTICS; BACTERIA; DRUG PRODUCTS; ELECTROPHORESIS; GENES; GENETIC ENGINEERING; PHYSIOLOGY; PROTEINS; THERMAL EFFECTS; TWO DIMENSIONAL; VITAMINS;

BACTERIOLOGY;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

BACTERIUM; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEOMICS; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; DRUG DESIGN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; MASS SPECTROMETRY; PROTEOMICS;

EID: 17144410529     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.20030     Document Type: Review

References (126)

1. Abergel C, Coutard B, Byrne D, Chenivesse S, Claude JB, Deregnaud C, Fricaux T, Gianesini-Boutreux C, Jeudy S, Lebrun R, Maza C, Notredame C, Poirot O, Suhre K, Varagnol M, Claverie JM. 2003. Structural genomics of highly conserved microbial genes of unknown targets in search of new antibacterial targets. J Struct Funct Genomics 4:141-157.
2. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
3. Agabian N, Unger B. 1978. Caulobacter crescentus cell envelope: Effect of growth conditions on murein and outer membrane protein composition. J Bacteriol 133:987-994.
4. Alksne LE. 2002. Virulence as a target for antimicrobial chemotherapy. Expert Opin Investig Drugs 11:1149-1159.
5. Allsop AE. 1998. New antibiotic discovery, novel screens, novel targets, and impact of microbial genomics. Curr Opin Microbiol 1:530-534.
6. Apfel CM, Locher H, Evers S, Takacs B, Hubschwerlen C, Pirson W, Page MG, Keck W. 2001. Peptide deformylase as an antibacterial drug target: Target validation and resistance development. Antimicrob Agents Chemother 45:1058-1064.
7. Appelbaum PC. 2002. Resistance among Streptococcus pneumoniae: Implications for drug selection. Clin Infect Dis 34:1613-1620.
8. Armitage JP, Dorman CJ, Hellingwerf K, Schmitt R, Summers D, Holland B. 2003. Micro meeting: Thinking and decision making, bacterial style: Bacterial Neural Networks, Obernai, France, 7th-12th June, 2002. Mol Microbiol 47:583-593.
9. Armstrong GL, Conn LA, Pinner RW. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281:61-66.
10. Bandow JE, Brötz H, Hecker H. 2002. Bacillus subtilis tolerance of moderate concentrations of rifampin involves the sigma(B)-dependent general and multiple stress response. J Bacteriol 184:459-467.
11. Bandow JE, Brötz H, Leichert LIO, Labischinski H, Hecker H. 2003a. Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemther 47:948-955.
12. Bandow J, Becher D, Büttner K, Hochgräfe F, Freiberg C, Brötz H, Hecker M. 2003b. The role of peptide deformylase in protein biosynthesis: A proteomic study. Proteomics 3:299-306.
13. Berggren K, Steinberg T, Lauber W, Carroll J, Lopez M, Chernokalskaya E, Zieske L, Diwu Z, Haugland R, Patton W. 1999. A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supports. Anal Biochem 279:129-143.
14. Bernhardt J, Büttner K, Scharf C, Hecker M. 1999. Dual channel imaging of two-dimensional electropherograms in Bacillus subtilis. Electrophoresis 20:2225-2240.
15. Bernhardt J, Weibezahn J, Scharf C, Hecker M. 2003. Bacillus subtilis during feast and famine: Visualization of the overall regulation of protein synthesis during glucose starvation by proteome analysis. Genome Res 13:224-237.
16. Beyer D, Kroll H-P, Endermann R, Schiffer G, Siegel S, Bauser M, Pohlmann J, Brands M, Ziegelbauer K, Haebich D, Eymann C, Brötz-Oesterhelt H. 2004. Discovery of a new class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad spectrum activity. Antimicrob Agents Chemother 48:525-532.
17. Boeddecker N, Bahador G, Gibbs C, Mabery E, Wolf J, Xu L, Watson J. 2002. Characterization of a novel antibacterial agent that inhibits bacterial translation. RNA 8:1120-1128.
18. Brands M, Endermann R, Gahlmann R, Kruger J, Raddatz S. 2003. Dihydropyrimidinones - A new class of anti-staphylococcal antibiotics. Bioorg Med Chem Lett 13:241-245.
19. Bush K. 2002. The impact of β-lactamses on the develoment of novel antimicrobial agents. Curr Opin Invest Drugs 3:1284-1290.
20. Cho MJ, Jeon BS, Park JW, Jung TS, Song JY, Lee WK, Choi YJ, Choi SH, Park SG, Park JU, Choe MY, Jung SA, Byun EY, Baik SC, Youn HS, Ko GH, Lim D, Rhee KH. 2002. Identifying the major proteome components of Helicobacter pylori strain 26695. Electrophoresis 23:1161 -1173.
21. Cordwell SJ, Nouwens AS, Verrills NM, Basseal DJ, Walsh BJ. 2000. Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels. Electrophoresis 21:1094-1103.
22. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ. 2002. Comparative proteotnics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100. Microbiology 148:2765-2781.
23. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. 2000. The dynamic range of protein expression: A challenge for proteomic research. Electrophoresis 21:1104-1115.
24. De Moreno MR, Smith JF, Smith RV. 1985. Silver staining of proteins in polyacrylamide gels: Increased sensitivity through combined Coomassie blue-silver stain procedure. Anal Biochem 151:466-470.
25. Drlica K, Zhao X. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61:377-392.
26. Edman P, Begg G. 1967. A protein sequenator. Eur J Biochem 1:80-91.
27. Evers S, Di Padova K, Meyer M, Langen H, Fountoulakis M, Keck W, Gray CP. 2001. Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors. Proteomics 1:522-544.
28. Eymann C, Homuth G, Scharf C, Hecker M. 2002. Bacillus subtilis functional genomics: Global characterization of the stringent response by proteome and transcriptome analysis. J Bacteriol 184:2500-2520.
29. Fischer HP, Brunner NA, Wieland B, Paquette J, Macko L, Ziegelbauer K, Freiberg C. 2004. Identification of antibiotic stress-inducible promoters: A systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. Genome Res 14:90-98.
30. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, McKenney K, Sutton G, FitzHugh W, Fields W, Gocayne JD, Scott J, Shirley R, Liu LI, Glodek A, Kelley JM, Weidman JF, Phillips CA, Spriggs A, Hedblom E, Cotton MD, Utterback TR, Hanna MC, Nguyen DT, Saudek DM, Brandon RC, Fine LD, Fritchman LJ, Fuhrmann JL, Geoghagen NSM, Gnehm CL, McDonald LA, Small KV, Fraser CM, Smith HO, Venter JC. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
31. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Hayness JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ. 2002. A proteomic view of the Plasmodium falciparum life cycle. Nature 419:537.
32. Gale EF, Cundliffe E, Reynolds PE, Richmond MH, Waring MJ. 1981. The molecular basis of antibiotic action. 2nd edition. London, UK: Wiley.
33. Glass JI, Belanger AE, Robertson GT. 2002. Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery. Curr Opin Microbiol 5:338-342.
34. Gmuender H, Kuratli K, Di Padova K, Gray CP, Keck W, Evers S. 2001. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: Combined transcription and translation analysis. Genome Res 11:28-42.
35. Godovac-Zimmermann J, Brown LR. 2001. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom Rev 20:1-57.
36. Gomes SL, Juliani MH, Maia JC, Silva AM. 1986. Heat shock protein synthesis during development in Caulobacter crescentus. J Bacteriol 168:923-930.
37. Graves PR, Haystead TAJ. 2002. Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 66:39-63.
38. Gray CP, Keck W. 1999. Bacterial targets and antibiotics: Genome-based drug discovery. Cell Mol Life Sci 56:779-787.
39. Guay DR. 2001. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 61:353-364.
40. Guina T, Purvine SO, Yi EC, Eng J, Goodlett DR, Aebersold R, Miller SI. 2003a. Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc Natl Acad Sci USA 100:2771-2776.
41. Guina T, Wu M, Miller SI, Purvine SO, Yi EC, Eng J, Goodlett DR, Aebersold R, Ernst RK, Lee KA. 2003b. Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation. J Am Soc Mass Spectrom 14:742-751.
42. Gygi SO, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999.
43. Görg A, Postel W, Günther S. 1988. The current state of two- dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9: 531-546.
44. Görg A, Obermaier C, Boguth G, Weiss W. 1999. Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: Wide pH gradients up to pH 12, longer separation distances and simplified procedures. Electrophoresis 20:712-717.
45. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. 2000. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037-1053.
46. Haas M, Beyer D, Gahlmann R, Freiberg C. 2001. YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases. Microbiology 147:1783-1791.
47. Hamdan M, Righetti PG. 2002. Modem strategies for protein quantification in proteome analysis: Advantages and limitations. Mass Spectrom Rev 21:287-302.
48. Hecker M. 2003. A proteomic view of cell physiology of Bacillus subtilis-Bringing the genome sequence to life. Adv Biochem Eng Biotechnol 83:57-92.
49. Hecker M, Engelmann S, Cordwell SJ. 2003. Proteomics of Staphylococcus aureus - Current state and future challenges. J Chromatogr B Analyt Technol Biomed Life Sci 787:179-195.
50. Hecker M, Schumann W, Völker U. 1996. Heat shock and general stress proteins in Bacillus subtilis. Mol Microbiol 19:417-428.
51. Hecker M, Völker U. 2001. General stress response of Bacillus subtilis and other bacteria. Adv Microb Physiol 44:35-91.
52. Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C. 1993. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 90:5011-5015.
53. Hiramatsu K, Cui L, Kuroda M, Ito T. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486-493.
54. Hoener B, Noach A, Andrup M, Yen TS. 1989. Nitrofurantoin produces oxidative stress and loss of glutathione and protein thiols in the isolated perfused rat liver. Pharmacology 38:363-373.
55. Johnson KW, Lofland D, Taylor S, Burli R, Gross M, Ayscough A, Moser H, Waller A, East S, Keavey K, Hu W, Girish S, Difuntorum S, Chen H, Garcia M, Hoch U, Clements J. 2003. Second generation PDF inhibitors for respiratory tract infections. Abstract F-1481,43rd ICAAC, Chicago, IL, 2003.
56. Kaderbhai NN, Broadhurst DI, Ellis DI, Goodacre R, Kell DB. 2003. Functional genomics via metabolic footprinting: Monitoring metabolite secretion by E. coil tryptophan metabolism mutants using FT-IR and direct injection electrospray mass spectrometry. Comp Funct Genome 4:376-391.
57. Klose J. 1975. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. Humangenetik 26:231-243.
58. Kolker E, Purvine S, Galperin MY, Stolyar S, Goodlett DR, Nesvizhskii AI, Keller A, Xie T, Eng JK, Yi E, Hood L, Picone AF, Cherny T, Tjaden BC, Siegel AF, Reilly TJ, Makarova KS, Palsson BO, Smith AL. 2003. Initial proteome analysis of model microorganism Haemophilus influenzae strain Rd KW20. J Bacteriol 185:4593-4602.
59. Kornilovska I, Nilsson I, Utt M, Ljungh A, Wadstrom T. 2002. Immunogenic proteins of Helicobacter pullorum, Helicobacter bills, and Helicobacter hepaticus identified by two-dimensional gel electrophoresis and immunoblotting. Proteomics 2:775-783.
60. Kosower NS, Kosower EM. 1995. Diamide: An oxidant probe for thiols. Methods Enzymol 251:123-133.
61. Krueger JH, Walker GC. 1984. groEL and dnaK genes of Escherichia coli are induced by UV irradiation and nalidixic acid in an htpR+-dependent fashion. Proc Natl Acad Sci USA 81:1499-1503.
62. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
63. Lahm HW, Langen H. 2000. Mass spectrometry: A tool for the identification of proteins separated by gels. Electrophoresis 21:2105-2114.
64. Langen H, Takacs B, Evers S, Berndt P, Lahm HW, Wipf B, Gray C, Fountoulakis M. 2000. Two-dimensional map of Haemophilus influenzae. Electrophoresis 21:411-429.
65. Lasonder E, Ishihama Y, Andersen JS, Vermunt A, Pain A, Sauerwein RW, Eling WM, Hall N, Waters AP, Stunnenberg HG, Mann M. 2002. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419:537-542.
66. Lee YM, Almqvist F, Hultgren SJ. 2003. Targeting virulence for antimicrobial chemotherapy. Curr Opin Pharmacol 3:513-519.
67. Li J, Steen H, Gygi SP. 2003. Protein profiling with cleavable isotope-coded affinity tag (ICAT) reagents: The yeast salinity stress response. Mol Cell Proteomics 2:1198-1204.
68. Lill J. 2003. Proteomic tools for quantitation by mass spectrometry. Mass Spectrom Rev 22:182-194.
69. Lilley KS, Razzaq A, Dupree P. 2002. Two-dimensional gel electrophoresis: Recent advances in sample preparation, detection and quantitation. Curr Opin Chem Biol 6:46-50.
70. Limburg E, Gahlmann R, Kroll HP, Beyer D. 2004. Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057. AAC 48:619-622.
71. Linn T, Losick R. 1976. The program of protein synthesis during sporulation in Bacillus subtilis. Cell 8:103-114.
72. Livermore DM. 2003. Linezolid in vitro: Mechanism and antibacterial spectrum. J Antimicrob Chemother 51(Suppl 2):ii9-ii16.
73. Lomovskaya O, Watkins WJ. 2001. Efflux pumps: Their role in antibacterial drug discovery. Curr Med Chem 8:1699-1711.
74. Mann M, Hendrickson RC, Pandey A. 2001. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70:437-473.
75. Mathesius U, Mulders S, Gao M, Teplitski M, Caetano-Anolles G, Rolfe BG, Bauer WD. 2003. Extensive and specific responses of a eukaryote to bacterial quorum-sensing signals. Proc Natl Acad Sci USA 100:1444-1449.
76. Mirgorodskaya OA, Kozmin YP, Titov MI, Korner R, Sonksen CP, Roepstorff P. 2000. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun Mass Spectrom 14:1226-1232.
77. Mollenkopf HJ, Mattow J, Schaible UE, Grade L, Kaufmann SH, Jungblut PR. 2002. Mycobacterial proteomes. Methods Enzymol 358:242-256.
78. Molloy MP, Phadke ND, Maddock JR, Andrews PC. 2001. Two-dimensional electrophoresis and peptide mass fingerprinting of bacterial outer membrane proteins. Electrophoresis 22:1686-1696.
79. Naumann D, Labischinski H. 1990. Process and device for rapid testing of the effects of agents on micro-organisms. International Patent WO 90/ 09454.
80. Neidhardt FC, Ingraham JL, Schaechter M. 1990. Physiology of the bacterial cell: A molecular approach. Sunderland, MA: Sinauer Publishing, pp 351-388.
81. Ng WL, Kazmierczak KM, Robertson GT, Gilmour R, Winkler ME. 2003. Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors. J Bacteriol 185:359-370.
82. Nyman TA. 2001. The role of mass spectrometry in proteome studies. Biomol Eng 18:221-227.
83. O'Farrell PH. 1975. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021.
84. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. 1999. Accurate quantitation of protein expression and site-specific phosphorylation. Proc Natl Sci USA 96:6591-6596.
85. Ohlmeier S, Scharf C, Hecker M. 2000. Alkaline proteins of Bacillus subtilis: First steps towards a two-dimensional alkaline master gel. Electro-phoresis 21:3701-3709.
86. Ong SE, Foster LJ, Mann M. 2003. Mass spectrometric-based approaches in quantitative proteomics. Methods 29:124-130.
87. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376-386.
88. Pasa-Tolic L, Lipton MS, Masselon CD, Anderson GA, Shen Y, Tolic N, Smith RD. 2002. Gene expression profiling using advanced mass spectrometric approaches. J Mass Spectrom 37:1185-1198.
89. Patton WF. 2000. A thousand points of light: The application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis 21:1123-1144.
90. Payne DJ, Wallis NG, Gentry DR, Rosenberg M. 2000. The impact of genomics on novel antibacterial targets. Curr Opin Drug Discov Dev 3:177-190.
91. Rabilloud T. 1999. Silver staining of 2-D electrophoresis gels. Methods Mol Biol 122:297-305.
92. Reeh S, Pedersen S, Neidhardt FC. 1977. Transient rates of synthesis of five aminoacyl-transfer ribonucleic acid synthetases during a shift-up of Escherichia coli. J Bacteriol 129:702-706.
93. Schmid MB. 2001. Microbial genomics - New targets, new drugs. Expert Opin Ther Targets 5:465-475.
94. Schmidt F, Donahoe S, Hagens K, Mattow J, Schaible UE, Kaufmann SH, Aebersold R, Jungblut PR. 2004. Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope coded affinity tag technology. Mol Cell Proteomics 3:24-42.
95. Sechi S, Oda Y. 2003. Quantitative proteomics using mass spectrometry. Curr Opin Chem Biol 7:70-77.
96. Shaw KJ, Morrow BJ. 2003. Transcriptional profiling and drug discovery. Curr Opin Pharmacol 3:508-512.
97. Shaw KJ, Miller N, Liu X, Lerner D, Wan J, Bittner A, Morrow BJ. 2003. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J Mol Microbiol Biotechnol 5:105-122.
98. Sievert DM, Boulton ML, Stoltman G, Johnson D, Stobierski MG, Downes FP, Somsel PA, Rudrik JT, Brown W, Hafeez W, Lundstrom T, Flanagan E, Johnson R, Mitchell J, Chang S. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 51:565-567.
99. Suva JM, Khan S, O'Brien PJ. 1993. Molecular mechanisms of nitrofurantoin-induced hepatocyte toxicity in aerobic versus hypoxic conditions. Arch Biochem Biophys 305:362-369.
100. Singh VK, Jayaswal RK, Wilkinson BJ. 2001. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett 199:79-84.
101. Steinberg T, Lauber W, Berggren K, Kemper C, Yue S, Patton W. 1999. Fluorescence detection of proteins in sodium dodecyl sulfatepolyacrylamide gels using environmentally benign, nonfixative, saline solution. Electrophoresis 21:497-508.
102. Strahilevitz J, Rubinstein E. 2002. Novel agents for resistant Gram-positive infections: A review. Int J Infect Dis 6(Suppl 1):S38-S46.
103. Suga H, Smith KM. 2003. Molecular mechanisms of bacterial quorum sensing as a new drug target. Curr Opin Chem Biol 7:586-591.
104. Sutton MD, Smith BT, Godoy VG, Walker GC. 2000. The SOS response: Recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu Rev Genet 34:479-497.
105. Switzer RC, Merril CR, Shifrin S. 1979. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 98:231-237.
106. Tang CM, Moxon ER. 2001. The impact of microbial genomics on antimicrobial drug development. Annu Rev Genomics Hum Genet 2:259-269.
107. Tao WA, Aebersold R. 2003. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr Opin Biotech 14:110-118.
108. Thoren K, Gustafsson E, Clevnert A, Larsson T, Bergstrom J, Nilsson CL. 2002. Proteomic study of non-typable Haemophilus influenzae. J Chromatogr B Analyt Technol Biomed Life Sci 782:219-226.
109. Tonella L, Hoogland C, Binz PA, Appel RD, Hochstrasser DF, Sanchez JC. 2001. New perspectives in the Escherichia coli proteome investigation. Proteomics 1:409-423.
110. Ueberle B, Frank R, Herrmann R. 2002. The proteome of the bacterium Mycoplasma pneumoniae: Comparing predicted open reading frames to identified gene products. Proteomics 2:754-764.
111. VanBogelen RA. 2003. Probing the molecular physiology of the microbial organism, Escherichia coli using proteomics. Adv Biochem Eng Biotechnol 83:27-55.
112. VanBogelen RA, Neidhardt FC. 1990. Ribosomes as sensors of heat and cold shock in Escherichia coli. Proc Natl Aead Sci USA 87:5589-5593.
113. VanBogelen RA, Schiller E, Thomas JD, Neidhardt FC. 1999. Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis 20:2149-2159.
114. Vandahl BB, Birkelund S, Demol H, Hoorelbeke B, Christiansen G, Vandekerckhove J, Gevaert K. 2001. Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 22:1204-1223.
115. Walsh C. 2003. Antibiotic resistance. In: Antibiotics - Actions, origins, resistance. Washington: ASM Press, pp 89-155.
116. Washburn MP, Wolters D, Yates JR III. 2001. Large-scale analysis of the yeast proteome by multi-dimensional protein identification technology. Nat Biotechnol 19:242-247.
117. Washburn MP, Ulaszek R, Deciu C, Schieltz DM, Yates JR III. 2002. Analysis of quantitative proteomic data generated via multi-dimensional protein identification technology. Anal Chem 74:1650-1657.
118. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KW, Humphrey-Smith I. 1995. Progress with gene product mapping of the Mullicutes Mycoplasma genitalium. Electrophoresis 16:1090-1094.
119. Weidenmaier C, Kristian SA, Peschel A. 2003. Bacterial resistance to antimicrobial host defenses - An emerging target for novel antiinfective strategies? Curr Drug Targets 4:643-649.
120. WHO. 2001. Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2. World Health Organization, Geneva, who.int/emc/amrpdfs/ WHO_Global_Strategy_English.pdf.
121. Wu CC, Yates JR III. 2003. The application of mass spectrometry to membrane proteomics. Nat Biotechnol 21:262-267.
122. Yarmush ML, Jayaraman A. 2002. Advances in proteomic technologies. Annu Rev Biomed Eng 4:349-373.
123. Yoshida M, Loo JA, Lepleya RA. 2001. Proteomics as a tool in the pharmaceutical drug design process. Curr Pharm Des 7:291-310.
124. Young FS, Neidhardt FC. 1978. Effect of inhibitors of elongation factor Tu on the metabolic regulation of protein synthesis in Escherichia coli. JBacteriol 135:675-686.
125. Zhang Y, Amzel LM. 2002. Tuberculosis drug targets. Curr Drug Targets. 3:131-154.
126. Ziebandt AK, Weber H, Rudolph J, Schmid R, Hoper D, Engelmann S, Hecker M. 2001. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 1:480-493.